RAS/MAPK
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
16
Fgfr Ras MAPK signaling is required for apical constriction via apical positioning of Rho associated kinase during mechanosensory organ formation
7
The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence
16
UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
12
LIN 39 and the EGFR/RAS/MAPK pathway regulate C elegans vulval morphogenesis via the VAB 23 zinc finger protein
12
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
14
<p>Diterpene Ginkgolides Exert an Antidepressant Effect Through the NT3-TrkA and Ras-MAPK Pathways</p>
16
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
13
Original Article Williams syndrome transcription factor is a target of pro-oncogenic Ser158 phosphorylation mediated by Ras-MAPK pathway in human breast cancer
8
Dusp6 attenuates Ras/MAPK signaling to limit zebrafish heart regeneration
12
Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
14
Harmine suppresses hyper-activated Ras–MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
16
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
15
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
12
Computational Biology of Ras Proteins
246
PHYLOGENETIC ANALYSIS OF RAS SUBFAMILY PROTEINS
11
Pharmaceutical standardization of Kapha Ketu Ras
5
A Non-Mendelian MAPK-Generated Hereditary Unit Controlled by a Second MAPK Pathway in Podospora anserina
28
Inhibition of RAS in diabetic nephropathy
12
Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies
17